IE63205B1 - 7-(1h-pyrrol-3-yl)-substituted 3,5-dihydroxyheptanoic acids, their corresponding Delta-lactones and salts, processes for their preparation, their use as medicaments, pharmaceutical products and intermediates - Google Patents
7-(1h-pyrrol-3-yl)-substituted 3,5-dihydroxyheptanoic acids, their corresponding Delta-lactones and salts, processes for their preparation, their use as medicaments, pharmaceutical products and intermediatesInfo
- Publication number
- IE63205B1 IE63205B1 IE209788A IE209788A IE63205B1 IE 63205 B1 IE63205 B1 IE 63205B1 IE 209788 A IE209788 A IE 209788A IE 209788 A IE209788 A IE 209788A IE 63205 B1 IE63205 B1 IE 63205B1
- Authority
- IE
- Ireland
- Prior art keywords
- formula
- compound
- methyl
- substituted
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873722806 DE3722806A1 (de) | 1987-07-10 | 1987-07-10 | 7-(1h-pyrrol-3-yl)-substituierte 3,5-dihydroxy-hept-6-ensaeuren, 7-(1h-pyrrol-3-yl)-substituierte 3,5-dihydroxy-heptansaeuren, ihre entsprechenden (delta)-lactone und salze, verfahren zu ihrer herstellung ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE882097L IE882097L (en) | 1989-01-10 |
| IE63205B1 true IE63205B1 (en) | 1995-04-05 |
Family
ID=6331291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE209788A IE63205B1 (en) | 1987-07-10 | 1988-07-08 | 7-(1h-pyrrol-3-yl)-substituted 3,5-dihydroxyheptanoic acids, their corresponding Delta-lactones and salts, processes for their preparation, their use as medicaments, pharmaceutical products and intermediates |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5055484A (enExample) |
| EP (1) | EP0300249B1 (enExample) |
| JP (1) | JPS6434959A (enExample) |
| KR (1) | KR890002135A (enExample) |
| AT (1) | ATE85324T1 (enExample) |
| AU (1) | AU1888088A (enExample) |
| DE (2) | DE3722806A1 (enExample) |
| DK (1) | DK384288A (enExample) |
| ES (1) | ES2043736T3 (enExample) |
| FI (1) | FI883247A7 (enExample) |
| GR (1) | GR3007611T3 (enExample) |
| HU (1) | HU208672B (enExample) |
| IE (1) | IE63205B1 (enExample) |
| IL (1) | IL87036A0 (enExample) |
| NO (1) | NO883072L (enExample) |
| NZ (1) | NZ225342A (enExample) |
| PH (1) | PH26375A (enExample) |
| PT (1) | PT87927B (enExample) |
| ZA (1) | ZA884918B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3826814A1 (de) * | 1988-08-06 | 1990-02-08 | Hoechst Ag | Neue 6-fluor-3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte |
| FI94339C (fi) * | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
| IT1237793B (it) * | 1989-12-21 | 1993-06-17 | Zambon Spa | Composti attivi come inibitori dell'enzima hmg-coa reduttasi |
| US5128366A (en) * | 1990-07-05 | 1992-07-07 | Shinogi & Co., Ltd. | Pyrrole derivatives |
| DE4243279A1 (de) * | 1992-12-21 | 1994-06-23 | Bayer Ag | Substituierte Triole |
| US7250444B2 (en) * | 2003-08-11 | 2007-07-31 | Pfizer Inc. | Pyrrole-based HMG-CoA reductase inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3928380A (en) * | 1973-03-29 | 1975-12-23 | Sterling Drug Inc | 1,1{40 -Spirobis(cyclopenta-{8 4,5-c{9 pyrroles) |
| US4647576A (en) * | 1984-09-24 | 1987-03-03 | Warner-Lambert Company | Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis |
| KR900001212B1 (ko) * | 1985-10-25 | 1990-02-28 | 산도즈 파마슈티칼스 코오포레이숀 | 메바로노락톤 및 그것의 유도체의 헤테로사이클릭 유사체 및 그것의 생산방법 및 약학적인 그것의 용도 |
| US4851427A (en) * | 1985-10-25 | 1989-07-25 | Sandoz Pharm. Corp. | Pyrrole analogs of mevalonolactone, derivatives thereof and pharmaceutical use |
| US4681893A (en) * | 1986-05-30 | 1987-07-21 | Warner-Lambert Company | Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis |
| NO881411L (no) * | 1987-04-14 | 1988-10-17 | Bayer Ag | Substituerte pyrroler. |
-
1987
- 1987-07-10 DE DE19873722806 patent/DE3722806A1/de not_active Withdrawn
-
1988
- 1988-07-01 EP EP88110533A patent/EP0300249B1/de not_active Expired - Lifetime
- 1988-07-01 ES ES88110533T patent/ES2043736T3/es not_active Expired - Lifetime
- 1988-07-01 AT AT88110533T patent/ATE85324T1/de not_active IP Right Cessation
- 1988-07-01 DE DE8888110533T patent/DE3878067D1/de not_active Expired - Fee Related
- 1988-07-07 FI FI883247A patent/FI883247A7/fi not_active Application Discontinuation
- 1988-07-07 PT PT87927A patent/PT87927B/pt not_active IP Right Cessation
- 1988-07-08 PH PH37199A patent/PH26375A/en unknown
- 1988-07-08 DK DK384288A patent/DK384288A/da not_active Application Discontinuation
- 1988-07-08 AU AU18880/88A patent/AU1888088A/en not_active Abandoned
- 1988-07-08 US US07/216,423 patent/US5055484A/en not_active Expired - Fee Related
- 1988-07-08 ZA ZA884918A patent/ZA884918B/xx unknown
- 1988-07-08 NO NO88883072A patent/NO883072L/no unknown
- 1988-07-08 HU HU883600A patent/HU208672B/hu not_active IP Right Cessation
- 1988-07-08 NZ NZ225342A patent/NZ225342A/en unknown
- 1988-07-08 JP JP63169159A patent/JPS6434959A/ja active Pending
- 1988-07-08 IE IE209788A patent/IE63205B1/en not_active IP Right Cessation
- 1988-07-08 IL IL87036A patent/IL87036A0/xx unknown
- 1988-07-09 KR KR1019880008546A patent/KR890002135A/ko not_active Withdrawn
-
1993
- 1993-04-09 GR GR930400426T patent/GR3007611T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI883247A7 (fi) | 1989-01-11 |
| AU1888088A (en) | 1989-01-12 |
| JPS6434959A (en) | 1989-02-06 |
| ES2043736T3 (es) | 1994-01-01 |
| US5055484A (en) | 1991-10-08 |
| DK384288D0 (da) | 1988-07-08 |
| FI883247A0 (fi) | 1988-07-07 |
| HUT48580A (en) | 1989-06-28 |
| IE882097L (en) | 1989-01-10 |
| HU208672B (en) | 1993-12-28 |
| DK384288A (da) | 1989-01-11 |
| KR890002135A (ko) | 1989-04-08 |
| IL87036A0 (en) | 1988-12-30 |
| DE3878067D1 (de) | 1993-03-18 |
| PT87927A (pt) | 1989-06-30 |
| GR3007611T3 (enExample) | 1993-08-31 |
| EP0300249B1 (de) | 1993-02-03 |
| PH26375A (en) | 1992-06-01 |
| NO883072L (no) | 1989-01-11 |
| ATE85324T1 (de) | 1993-02-15 |
| EP0300249A1 (de) | 1989-01-25 |
| ZA884918B (en) | 1989-01-18 |
| DE3722806A1 (de) | 1989-01-19 |
| NO883072D0 (no) | 1988-07-08 |
| NZ225342A (en) | 1991-03-26 |
| PT87927B (pt) | 1995-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR0142880B1 (ko) | 3,5-디하이드록시헵트-6-인산의 7-치환된 유도체, 이의 제조방법 및 이를 포함하는 약제학적 생성물 | |
| Jendralla et al. | Synthesis and biological activity of new HMG-CoA reductase inhibitors. 2. Derivatives of 7-(1H-pyrrol-3-yl)-substituted-3, 5-dihydroxyhept-6 (E)-enoic (-heptanoic) acids | |
| DK157543B (da) | Pyrazolanaloge af mevalonolacton og derivater deraf samt deres anvendelse | |
| RU2012554C1 (ru) | Способ получения производных бензоциклоалкенилдигидрооксиалкановых кислот | |
| US4946841A (en) | Pyridazine 3,5-dihydroxy carboxylic acids and derivatives thereof, the use thereof for hypercholesterolemia | |
| EP0051917B1 (en) | Benzofuran ethanolamine derivatives, processes for their preparation, and their use in medicine | |
| HU204038B (en) | Process for producing tetrazole derivatives lowering pathologically high cholesterol level of blood | |
| US4503072A (en) | Antihypercholesterolemic compounds | |
| EP0068038B1 (en) | (+)-(4r,6s)-(e)-6-(2-(4'-fluoro-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2h-pyran-2-one, a process for preparing and a pharmaceutical composition containing the same | |
| EP0312269B1 (en) | 3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents | |
| CA2107150C (fr) | Nouveaux derives chromeniques a chaine laterale trienique, leur procede de preparation et les compositions pharmaceutiques les renfermant | |
| US4829081A (en) | Analogs of mevalonolactone and derivatives thereof | |
| JPH0257550B2 (enExample) | ||
| HU208691B (en) | Method for producing disubstituted pyridine derivatives and medical preparatives containing them | |
| IE63205B1 (en) | 7-(1h-pyrrol-3-yl)-substituted 3,5-dihydroxyheptanoic acids, their corresponding Delta-lactones and salts, processes for their preparation, their use as medicaments, pharmaceutical products and intermediates | |
| US4751235A (en) | Anti-atherosclerotic indolizine derivatives | |
| US4927851A (en) | Analogs of mevalonolactone and derivatives thereof | |
| IE63491B1 (en) | New 6-fluoro-3,5-dihydroxy carboxylic acids and derivatives thereof, a process for the preparation thereof, the use thereof as medicinal agents, pharmaceutical products and intermediates | |
| FI90412B (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3,5-dihydroksikarboksyylihappojohdannaisten valmistamiseksi | |
| DK169127B1 (da) | 3-Desmethyl-mevalonsyrederivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat indeholdende disse forbindelser | |
| US4051261A (en) | 1-(p-alkanoylphenyl) alkanols and derivatives | |
| JPH0283361A (ja) | 抗過コレステロール血症ニトリル化合物 | |
| JPS588076A (ja) | （＋）−（４ｒ，６ｓ）−（ｅ）−６−〔２−（４′−フルオロ−３，３′，５−トリメチル−〔１，１′−ビフエニル〕−２−イル）エテニル〕−３，４，５，６−テトラヒドロ−４−ヒドロキシ−２ｈ−ピラン−２−オ | |
| CS219922B4 (cs) | Způsob přípravy (+ )- (4R,6S)-(E)-6-['2- (4‘-fluor-3,3‘,5-trimethyl-/l,l‘- -bifenyl/-2-yl) ethenyíJ -3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-onu | |
| WO1993024478A1 (fr) | Derive heterocyclique substitue possedant un effet inhibiteur de la squalene epoxydase, et son utilisation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |